Inventor

FAN PINGCHEN

US62 patents

⚠️ This page may combine multiple inventors who share the name “FAN PINGCHEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CHEMOCENTRYX INC

42 patents

US10035768B2Jul 31, 2018

C5aR antagonists

CHEMOCENTRYX INC23 citations94

US9573897B2Feb 21, 2017

C5AR antagonists

CHEMOCENTRYX INC24 citations94

US8906938B2Dec 9, 2014

C5aR antagonists

CHEMOCENTRYX INC28 citations92

US9745268B2Aug 29, 2017

Processes and intermediates in the preparation of C5aR antagonists

CHEMOCENTRYX INC11 citations91

US11485708B2Nov 1, 2022

Compounds for treatment of PD-L1 diseases

CHEMOCENTRYX INC9 citations86

US11266643B2Mar 8, 2022

Triaryl compounds for treatment of PD-L1 diseases

CHEMOCENTRYX INC13 citations86

US10562896B2Feb 18, 2020

6-5 fused rings as C5a inhibitors

CHEMOCENTRYX INC11 citations86

US11713307B2Aug 1, 2023

Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases

CHEMOCENTRYX INC8 citations85

US11384079B2Jul 12, 2022

6-5 fused rings as C5a inhibitors

CHEMOCENTRYX INC5 citations84

US10828285B2Nov 10, 2020

Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors

CHEMOCENTRYX INC5 citations84

US10759807B2Sep 1, 2020

Diaryl substituted 5,5-fused ring compounds as C5aR inhibitors

CHEMOCENTRYX INC7 citations84

US10683294B2Jun 16, 2020

5-5 fused rings as C5a inhibitors

CHEMOCENTRYX INC8 citations84

US10660897B2May 26, 2020

C5aR antagonists

CHEMOCENTRYX INC6 citations84

US10532982B2Jan 14, 2020

Processes and intermediates in the preparation of C5aR antagonists

CHEMOCENTRYX INC4 citations84

US10487098B2Nov 26, 2019

Soluble C5aR antagonists

CHEMOCENTRYX INC6 citations84

US10329314B2Jun 25, 2019

Soluble C5aR antagonists

CHEMOCENTRYX INC12 citations84

US10266492B2Apr 23, 2019

Processes and intermediates in the preparation of C5aR antagonists

CHEMOCENTRYX INC8 citations84

US9750722B2Sep 5, 2017

Diazole amides

CHEMOCENTRYX INC5 citations84

US9328116B2May 3, 2016

Diazole lactams

CHEMOCENTRYX INC4 citations84

US9169248B2Oct 27, 2015

Diazole amides

CHEMOCENTRYX INC6 citations84

US8916601B2Dec 23, 2014

Aza-aryl 1H-pyrazol-1-YL benzene sulfonamides

CHEMOCENTRYX INC12 citations84

US11485737B2Nov 1, 2022

Diaryl substituted 5,5-fused ring compounds as C5aR inhibitors

CHEMOCENTRYX INC2 citations73

US11478460B2Oct 25, 2022

Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors

CHEMOCENTRYX INC3 citations73

US11479553B2Oct 25, 2022

5-5 fused rings as C5a inhibitors

CHEMOCENTRYX INC3 citations73

US11434230B2Sep 6, 2022

2-oxindole compounds

CHEMOCENTRYX INC1 citations73

US11254695B2Feb 22, 2022

Soluble C5aR antagonists

CHEMOCENTRYX INC1 citations73

US10759789B2Sep 1, 2020

2-oxindole compounds

CHEMOCENTRYX INC2 citations73

US10744118B2Aug 18, 2020

Diazole lactams

CHEMOCENTRYX INC2 citations73

US10596163B2Mar 24, 2020

Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides

CHEMOCENTRYX INC3 citations73

US10421748B2Sep 24, 2019

2-oxindole compounds

CHEMOCENTRYX INC3 citations73

US10137120B2Nov 27, 2018

Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides

CHEMOCENTRYX INC2 citations73

US12268675B2Apr 8, 2025

Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors

CHEMOCENTRYX INC0 citations63

US11807609B2Nov 7, 2023

Deuterated compounds as immunomodulators

CHEMOCENTRYX INC0 citations63

US11773091B2Oct 3, 2023

6-5 fused rings as C5a inhibitors

CHEMOCENTRYX INC0 citations63

US11608336B2Mar 21, 2023

Prodrugs of fused-bicyclic C5aR antagonists

CHEMOCENTRYX INC1 citations63

US12533354B2Jan 27, 2026

Triaryl compounds for treatment of PD-L1 diseases

CHEMOCENTRYX INC0 citations62

US12497383B2Dec 16, 2025

Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases

CHEMOCENTRYX INC0 citations62

US12371433B2Jul 29, 2025

Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases

CHEMOCENTRYX INC0 citations62

US12139475B2Nov 12, 2024

2-oxindole compounds

CHEMOCENTRYX INC0 citations62

US11866429B2Jan 9, 2024

Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases

CHEMOCENTRYX INC0 citations62

US11845729B2Dec 19, 2023

Processes and intermediates in the preparation of C5aR antagonists

CHEMOCENTRYX INC0 citations62

US11759454B2Sep 19, 2023

Diazole lactams

CHEMOCENTRYX INC0 citations62

FAN PINGCHEN

2 patents

US9126939B2Sep 8, 2015

C5AR antagonists

FAN PINGCHEN30 citations93

US8445515B2May 21, 2013

C5aR antagonists

FAN PINGCHEN38 citations93

AMGEN INC

2 patents

US7045527B2May 16, 2006

Piperidine derivatives

AMGEN INC39 citations92

US7148259B1Dec 12, 2006

Antibacterial agents

AMGEN INC23 citations91

CHEN XI

2 patents

US8853202B2Oct 7, 2014

Modulators of CXCR7

CHEN XI4 citations72

US8288373B2Oct 16, 2012

Modulators of CXCR7

CHEN XI5 citations62

TULARIK INC

1 patent

US6780858B2Aug 24, 2004

Antibacterial agents

TULARIK INC35 citations91

CONNORS RICHARD V

1 patent

US8841312B2Sep 23, 2014

Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors

CONNORS RICHARD V6 citations80

Showing the top 50 of 62 patents by PatentIndex Score.